Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on Sep 15, 2025 - 3:59PM >>   ABB 5338.95 [ 1.78 ]ACC 1859 [ 0.49 ]AMBUJA CEM 569.3 [ 1.58 ]ASIAN PAINTS 2502.1 [ -1.66 ]AXIS BANK 1104.3 [ -0.09 ]BAJAJ AUTO 9026.6 [ 0.33 ]BANKOFBARODA 239 [ 0.65 ]BHARTI AIRTE 1907.2 [ 0.16 ]BHEL 229.5 [ 0.35 ]BPCL 318.3 [ 0.09 ]BRITANIAINDS 6213.35 [ -0.50 ]CIPLA 1549 [ -1.58 ]COAL INDIA 394.5 [ 0.08 ]COLGATEPALMO 2363.9 [ 0.45 ]DABUR INDIA 541.2 [ 0.45 ]DLF 775.65 [ 2.30 ]DRREDDYSLAB 1301.85 [ -1.11 ]GAIL 180 [ 0.81 ]GRASIM INDS 2809.25 [ 0.29 ]HCLTECHNOLOG 1463.1 [ -0.25 ]HDFC BANK 966.7 [ -0.02 ]HEROMOTOCORP 5286.25 [ -0.25 ]HIND.UNILEV 2579.6 [ -0.03 ]HINDALCO 753.25 [ -0.63 ]ICICI BANK 1419.5 [ 0.13 ]INDIANHOTELS 791.05 [ 1.68 ]INDUSINDBANK 739.8 [ -0.12 ]INFOSYS 1508.05 [ -1.15 ]ITC LTD 412.8 [ -0.19 ]JINDALSTLPOW 1046.05 [ 1.02 ]KOTAK BANK 1968 [ -0.21 ]L&T 3591.45 [ 0.33 ]LUPIN 2046.85 [ 0.20 ]MAH&MAH 3529.35 [ -1.67 ]MARUTI SUZUK 15275 [ -0.33 ]MTNL 44.91 [ 2.16 ]NESTLE 1212.7 [ -0.39 ]NIIT 111.45 [ 1.32 ]NMDC 75.5 [ -1.33 ]NTPC 331.25 [ -0.15 ]ONGC 232.25 [ -0.45 ]PNB 108.45 [ 1.02 ]POWER GRID 286.4 [ -0.37 ]RIL 1399.3 [ 0.32 ]SBI 824.9 [ 0.19 ]SESA GOA 454.35 [ 0.75 ]SHIPPINGCORP 214.75 [ 0.23 ]SUNPHRMINDS 1602.45 [ -0.85 ]TATA CHEM 975.2 [ 1.46 ]TATA GLOBAL 1099.5 [ -0.32 ]TATA MOTORS 712.7 [ -0.32 ]TATA STEEL 169.2 [ -0.35 ]TATAPOWERCOM 387.9 [ 0.43 ]TCS 3111.5 [ -0.72 ]TECH MAHINDR 1519.7 [ -0.39 ]ULTRATECHCEM 12429.05 [ 0.46 ]UNITED SPIRI 1315 [ 0.43 ]WIPRO 251.2 [ -0.28 ]ZEETELEFILMS 115.05 [ -0.99 ] BSE NSE
You can view full text of the latest Auditor's Report for the company.

BSE: 540596ISIN: INE406M01024INDUSTRY: Pharmaceuticals

BSE   ` 1660.00   Open: 1670.05   Today's Range 1660.00
1691.30
-16.60 ( -1.00 %) Prev Close: 1676.60 52 Week Range 1130.05
1909.55
Year End :2025-03 

To The Members of Eris Lifesciences Limited

Report on the Audit of the Standalone Financial Statements

Opinion

We have audited the accompanying standalone financial statements of Eris Lifesciences Limited (the "Company"), which comprise the Balance Sheet as at March 31, 2025, and the Statement of Profit and Loss (including Other Comprehensive Income), the Statement of Cash Flows and the Statement of Changes in Equity for the year ended on that date, and notes to the financial statements, including a summary of material accounting policies and other explanatory information.

In our opinion and to the best of our information and according to the explanations given to us, the aforesaid standalone financial statements give the information required by the Companies Act, 2013 (the "Act") in the manner so required and give a true and fair view in conformity with the Indian Accounting Standards prescribed under section 133 of the Act, ("Ind AS") and other accounting principles generally accepted in India, of the state of affairs of the Company as at March 31, 2025, and its profit, total comprehensive income, its cash flows and the changes in equity for the year ended on that date.

Basis for Opinion

We conducted our audit of the standalone financial statements in accordance with the Standards on Auditing ("SA"s) specified under section 143(10) of the Act. Our responsibilities under those Standards are further described in the Auditor's Responsibility for the Audit of the Standalone Financial Statements section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India ("ICAI") together with the ethical requirements that are relevant to our audit of the standalone financial statements under the provisions of the Act and the Rules made thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the ICAI's Code of Ethics. We believe that the audit evidence obtained by us is sufficient and appropriate to provide a basis for our audit opinion on the standalone financial statements.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the standalone financial statements of the current period. These matters were addressed in the context of our audit of the standalone financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters. We have determined the matters described below to be the key audit matters to be communicated in our report.

Sr. No.

Key Audit Matter

Auditor's Response

1

Business Combination - Acquisition of Indian Branded Formulation from Biocon Biologics Limited.

(Refer to Note 27.1 to the Standalone Financial Statements)

During the current financial year, the Company has acquired Indian Branded Formulations business from Biocon Biologics Limited for a consideration of Rs. 1,242 Crore in a Slump sale transaction.

Principal audit procedures performed:

1. Our audit procedures included a combination of testing the Design, Implementation and Operating effectiveness of controls over determination of fair values of assets acquired and liabilities assumed for the purpose of purchase price allocation.

The Company has accounted the acquisition under

2. Our substantive procedures included,

the acquisition method of accounting for business

(i) Evaluating the competencies, capabilities and

combinations. Accordingly, the purchase price was

objectivity of the independent valuation specialist

allocated to the assets acquired and liabilities assumed

engaged by the Company to carry out Purchase Price

based on their fair values on the acquisition dates.

Allocation (PPA) of the Business Combination

The determination of such fair values for the purpose

(ii) Considering and evaluating cash flow projections,

of purchase price allocation involves judgments and

the reasonableness of key assumptions including

estimates such as appropriateness of the valuation methodology applied, and the discount rates applied to

revenue growth rates and net profit margin

future cash flow forecasts.

(iii) With the assistance of our fair value specialists, we evaluated (a) the appropriateness of the valuation

In view of the foregoing, Purchase Price Allocation in

methodologies for identified intangibles and (b)

respect of the Business Combination has been identified

reasonableness of the key valuation assumptions

as a Key Audit Matter.

viz. discount rate / contributory asset charge, as applicable including testing the source information underlying the determination of the discount rate, and developing a range of independent estimates and comparing those to the discount rate selected by independent valuers and relied upon by the management.

Information Other than the Financial Statements and Auditor's Report Thereon

• The Company's Board of Directors is responsible for the other information. The other information comprises the information included in the Management Discussion and Analysis, Board's Report including Annexures to Board's Report, Business Responsibility and Sustainability Report and Corporate Governance Report in Annual Report for the year ended March 31, 2025, but does not include the consolidated financial statements, standalone financial statements and our auditor's report thereon. These reports are expected to be made available to us after the date of this auditor's report.

• Our opinion on the standalone financial statements does not cover the other information and will not express any form of assurance conclusion thereon.

• In connection with our audit of the standalone financial statements, our responsibility is to read the other information, identified above when it becomes available and, in doing so, consider whether the other information is materially inconsistent with the standalone financial statements, or our knowledge obtained during the course of our audit or otherwise appears to be materially misstated.

• When we read the other information identified above, if we conclude that there is a material misstatement therein, we are required to communicate the matter to those charged with governance as required under SA 720 'The Auditor's responsibilities Relating to Other Information.

Responsibilities of Management and Board of Directors for the Standalone Financial Statements

The Company's Board of Directors is responsible for the matters stated in section 134(5) of the Act with respect to the preparation of these standalone financial statements that give a true and fair view of the financial position, financial performance including other comprehensive income, cash flows and changes in equity of the Company in accordance with the accounting principles generally accepted in India including Ind AS specified under section 133 of the Act. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records,

relevant to the preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.

In preparing the standalone financial statements, management and Board of Directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intend to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

The Company's Board of Directors is also responsible for overseeing the Company's financial reporting process.

Auditor's Responsibility for the Audit of the Standalone Financial Statements

Our objectives are to obtain reasonable assurance about whether the standalone financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these standalone financial statements.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

• Identify and assess the risks of material misstatement of the standalone financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

• Obtain an understanding of internal financial controls relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under section 143(3)0) of the Act, we are also responsible for expressing our opinion on whether the Company has adequate internal financial controls with reference to standalone financial statements in place and the operating effectiveness of such controls.

• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the management.

• Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the standalone financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.

• Evaluate the overall presentation, structure and content of the standalone financial statements, including the disclosures, and whether the standalone financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

Materiality is the magnitude of misstatements in the standalone financial statements that, individually or in aggregate, makes it probable that the economic decisions of a reasonably knowledgeable user of the standalone financial statements may be influenced. We consider quantitative materiality and qualitative factors in (i) planning the scope of our audit work and in evaluating the results of our work; and (ii) to evaluate the effect of any identified misstatements in the standalone financial statements.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal financial controls that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the standalone financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor's report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

Report on Other Legal and Regulatory Requirements

1. As required by Section 143(3) of the Act, based on our audit we report that:

a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purposes of our audit.

b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those books except in relation to compliance with the requirements of audit trail, refer paragraph (i)(vi) below.

c) The Balance Sheet, the Statement of Profit and Loss including Other Comprehensive Income, the Statement of Cash Flows and Statement of Changes in Equity dealt with by this Report are in agreement with the relevant books of account.

d) In our opinion, the aforesaid standalone financial statements comply with the Ind AS specified under Section 133 of the Act.

e) On the basis of the written representations received from the directors as on March 31, 2025, taken on record by the Board of Directors, none of the directors is disqualified as on March 31, 2025, from being appointed as a director in terms of Section 164(2) of the Act

f) The modifications relating to the maintenance of accounts and other matters connected therewith, is as stated in paragraph (b) above.

g) With respect to the adequacy of the internal financial controls with reference to standalone financial statements of the Company and the operating effectiveness of such controls, refer to our separate Report in "Annexure A". Our report expresses an unmodified opinion on the adequacy and operating effectiveness of the Company's internal financial controls with reference to standalone financial statements.

h) With respect to the other matters to be included in the Auditor's Report in accordance with the requirements of section 197(16) of the Act, as amended, in our opinion and to the best of our information and according to the explanations given to us, the remuneration paid by the Company to its directors during the year is in accordance with the provisions of section 197 of the Act.

i) With respect to the other matters to be included in the Auditor's Report in accordance with Rule 11 of the Companies (Audit and Auditors) Rules, 2014, as amended in our opinion and to the best of our information and according to the explanations given to us:

i. The Company has disclosed the impact of pending litigations on its financial position in its standalone financial statements - Refer Note 33 to the standalone financial statements.

ii. The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses.

iii. There were no amounts which were required to be transferred to the Investor Education and Protection Fund by the Company.

iv. (a) The Management has represented that, to the best of its knowledge and belief, as disclosed in the note 37(B)(i)

to the financial statements no funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or in any other person(s) or entity(ies), including foreign entities ("Intermediaries"), with the understanding, whether recorded in writing or otherwise, that the Intermediary shall, directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company ("Ultimate Beneficiaries") or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

(b) The Management has represented, that, to the best of its knowledge and belief, as disclosed in the note 37(B)(ii) to the financial statements, no funds have been received by the Company from any person(s) or entity(ies), including foreign entities ("Funding Parties"), with the understanding, whether recorded in writing or otherwise, that the Company shall, directly or indirectly, lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party ("Ultimate Beneficiaries") or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

(c) Based on the audit procedures performed that have been considered reasonable and appropriate in the circumstances, nothing has come to our notice that has caused us to believe that the representations under subclause (i) and (ii) of Rule 11(e), as provided under (a) and (b) above, contain any material misstatement.

v. The interim dividend declared and paid by the Company during the year is in accordance with Section 123 of the Companies Act 2013.

vi. Based on our examination, which included test checks, the Company has used an accounting software for maintaining its books of account for the year ended March 31, 2025, which has a feature of recording audit trail (edit log) facility and the same has operated throughout the year for all relevant transactions recorded in the software except that audit trail has not been enabled in respect of changes made by users with privileged access, as stated in Note 37(B) to the financial statements.

Further, during the course of our audit, we did not come across any instance of the audit trail feature being tampered with, in respect of said accounting software for the period for which the audit trail feature was enabled and operating.

Additionally, the audit trail that was enabled and operated for the year ended March 31, 2024, has been preserved by the Company as per the statutory requirements for record retention, as stated in Note 37(B) to the financial statements.

2. As required by the Companies (Auditor's Report) Order, 2020 ("the Order") issued by the Central Government in terms of Section 143(11) of the Act, we give in "Annexure B" a statement on the matters specified in paragraphs 3 and 4 of the Order.

For Deloitte Haskins & Sells LLP

Chartered Accountants (Firm's Registration No. 117366W/W-100018)

Hardik Sutaria

Partner

(Membership No. 116642) (UDIN: 25116642BMLMWT6414)

Place: Ahmedabad

Date: May 19, 2025